Major histocompatibility complex expression and lung ischemia-reperfusion in rats

Area of Science:

• Transplantation immunology
• Organ injury research

Background:

• Poor early graft function in kidney and liver transplants correlates with increased graft loss due to rejection.
• Ischemia-reperfusion injury is implicated in transplant rejection by increasing graft immunogenicity.

Purpose of the Study:

• To investigate the impact of ischemia-reperfusion injury on major histocompatibility complex (MHC) antigen expression in a rat lung model.
• To assess the influence of lung deflation during ischemia and concurrent allostimulation on MHC expression.

Main Methods:

• Utilized a rat model of unilateral in situ pulmonary ischemia-reperfusion.
• Examined class II major histocompatibility complex (MHC) antigen expression 9 days post-ischemia using radiolabeled antibody binding and immunohistochemistry.
• Evaluated the effects of ischemia duration, lung deflation, and allogeneic mononuclear cell or F1 cell administration.

Main Results:

• Four hours of ischemia or 2 hours of atelectatic ischemia caused severe lung injury and increased MHC expression in the ischemic lung compared to the non-ischemic side.
• Lung deflation during ischemia exacerbated both lung injury and MHC expression.
• Concurrent allostimulation with foreign mononuclear cells potentiated the increase in MHC expression in the ischemic lung.

Conclusions:

• Severe ischemic lung injury significantly increases MHC expression for at least 9 days post-reperfusion.
• Lung deflation during ischemia amplifies both injury and subsequent MHC expression.
• Increased graft MHC expression following ischemia-reperfusion and allostimulation may heighten immunogenicity and transplant rejection risk.